Article
Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors.
American journal of clinical pathology - 1 Dec 2016
Merten Larissa, Agaimy Abbas, Moskalev Evgeny A, Giedl Johannes, Kayser Claudia, Geddert Helene, Schaefer Inga-Marie, Cameron Silke, Werner Martin, Ströbel Philip, Hartmann Arndt, Haller Florian
Abstract excerpt
OBJECTIVES: Loss-of-function mutations in TP53 and CDKN2A have been found at varying frequencies in gastrointestinal stromal tumors (GISTs), while no mutations of RB1 have been reported to date. The aim of the current study was to determine the mutation frequency of TP53, RB1, and CDKN2A in GISTs. METHODS: A cohort of 83 primary untreated GISTs was analyzed for mutations in TP53, RB1, and CDKN2A by massive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
